Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. DNA & RNA Banking Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Industry Analysis - Porter’s
3.3.1. Supplier power
3.3.2. Buyer power
3.3.3. Substitution threat
3.3.4. Threat of new entrant
3.3.5. Competitive rivalry
3.4. PESTEL Analysis
3.4.1. Political landscape
3.4.2. Technological landscape
3.4.3. Economic landscape
Chapter 4. DNA & RNA Banking Services Market: Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. DNA & RNA Banking Services Market: Service Movement Analysis, 2023 & 2030 (USD Million)
4.3. Transportation Service
4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4. Processing Service
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Storage Service
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Quality Control Service
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Data Storage
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Others
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. DNA & RNA Banking Services Market: Specimen Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. DNA & RNA Banking Services Market: Specimen Movement Analysis, 2023 & 2030 (USD Million)
5.3. Blood
5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4. Buccal Swabs & Hair Follicles
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Others
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. DNA & RNA Banking Services Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. DNA & RNA Banking Services Market: Application Movement Analysis, 2023 & 2030 (USD Million)
6.3. Therapeutics
6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4. Drug Discovery & Clinical Research
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Clinical Diagnostics
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Other Applications
6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. DNA & RNA Banking Services Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. DNA & RNA Banking Services Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
7.3. Academic Research
7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Hospitals & Diagnostic Centers
7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Others
7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. DNA & RNA Banking Services Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. U.S.
8.5.1.1. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. Canada
8.5.2.1. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
8.6.1. UK
8.6.1.1. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Germany
8.6.2.1. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. France
8.6.3.1. France market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. Italy
8.6.4.1. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Spain
8.6.5.1. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Norway
8.6.6.1. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Sweden
8.6.7.1. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.6.8. Denmark
8.6.8.1. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Japan
8.7.1.1. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. China
8.7.2.1. China market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. India
8.7.3.1. India market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Australia
8.7.4.1. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.5. South Korea
8.7.5.1. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.7.6. Thailand
8.7.6.1. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. Argentina
8.8.2.1. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. MEA
8.9.1. South Africa
8.9.1.1. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.9.2. Saudi Arabia
8.9.2.1. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.9.3. UAE
8.9.3.1. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.9.4. Kuwait
8.9.4.1. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.4. Company Profiles
9.4.1. EasyDNA
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Service benchmarking
9.4.1.4. Strategic initiatives
9.4.2. DNA Genotek Inc.
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Service benchmarking
9.4.2.4. Strategic initiatives
9.4.3. 23andMe, Inc.
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Service benchmarking
9.4.3.4. Strategic initiatives
9.4.4. GoodCell
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Service benchmarking
9.4.4.4. Strategic initiatives
9.4.5. ProteoGenex
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Service benchmarking
9.4.5.4. Strategic initiatives
9.4.6. US Biolab Corporation, Inc.
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Service benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Infinity Biologix
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Service benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Thermo Fisher Scientific, Inc.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Service benchmarking
9.4.8.4. Strategic initiatives
9.4.9. deCODE genetics
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Service benchmarking
9.4.9.4. Strategic initiatives
9.4.10. AG Brooks Life Sciences
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Service benchmarking
9.4.10.4. Strategic initiatives
9.4.11. LGC Biosearch Technologies
9.4.11.1. Company overview
9.4.11.2. Financial performance
9.4.11.3. Service benchmarking
9.4.11.4. Strategic initiatives
9.4.12. PreventionGenetics
9.4.12.1. Company overview
9.4.12.2. Financial performance
9.4.12.3. Service benchmarking
9.4.12.4. Strategic initiatives